Cara Frosch, MBA, PA
Pearl IRB announces the hiring of Cara Frosch, MBA, PA as Director of Business Development.
Frosch brings over 35 years of diversified biopharmaceutical and medical device experience in human and animal health to Pearl IRB and Pearl Pathways. After a short stint in clinical practice as a Physician Assistant (PA), Frosch held roles of increasing responsibility in virtually every phase of product development, from diagnostic assay development and global regulatory affairs to clinical research operations and corporate strategic planning.
Frosch’s career includes considerable leadership experience across small and large sponsor companies including Abbott, BioVeris, and MedImmune. Most recently, Frosch spent 12 years at Eli Lilly & Company / Elanco, where she led new product planning, global portfolio, and market intelligence initiatives.
As Director of Business Development, Frosch will exercise her passion for marketing and new product development to lead the business development strategy and process for Pearl Pathways. Her innovative approach to portfolio and project management, market intelligence tools, data analytics, and process improvement will help Pearl Pathways’ expert regulatory, quality, and clinical teams serve more life science companies.
Gretchen Bowker, CEO, shares “Our clients will benefit from Cara’s extensive leadership experience across sponsors and service providers, from the lab bench through product commercialization. Cara has a proven track record of providing forward-thinking leadership to ensure cross-functional collaboration, building stakeholder value, and delivering results. We are thrilled to have Cara join our team.”
To learn more, view the full press release or Cara Frosch’s bio.